HCPCS J9044

Injection, bortezomib, not otherwise specified, 0.1 mg

HCPCS Information

HCPCS Code: J9044
The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J9044 identifies the type of service or supply used while any of the 11 NDC codes below could be used to specify the exact drug used.
Short Description
Inj, bortezomib, nos, 0.1 mg
Long Description
Injection, bortezomib, not otherwise specified, 0.1 mg
Pricing Indicator
Drugs
Multiple Pricing Indicator
Not applicable as HCPCS priced under one methodology
Coverage Description
Carrier judgment
BETOS Type of Service
Other drugs
HCPCS Classification
List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)

HCPCS Crossover to NDC Codes

The NDC codes below allow precise billing based on the specific manufacturer and medication used:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0143-9098Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
10019-991Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBaxter Healthcare CorporationACTIVE
25021-244Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
43598-865Bortezomib Dr.reddy's Laboratories Inc
50742-484Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousIngenus Pharmaceuticals, LlcACTIVE
55150-337Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousEugia Us LlcACTIVE
60505-6050Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousApotex CorpACTIVE
63323-721Bortezomib Fresenius Kabi Usa, Llc
68001-540Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
68001-541Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
70710-1411Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousZydus Pharmaceuticals Usa Inc.ACTIVE